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Background
The interaction and the energetics of small molecule binding to a protein largely depend 
on the molecular architecture and microenvironment provided due to folding/unfold-
ing or even transformation of the protein structure. The observable properties of a small 
Abstract 
Fluorescence emission and anisotropy are widely used to measure the binding param-
eters and kinetic behavior of reactions that cause a change in the rotational time of a 
fluorescent molecule. We report here fluorescence emission and anisotropy behavior 
of a newly synthesized novel naphthalene base fluorophore (methyl 3-[(6-{[2-(tert-
butoxy)-2-oxoethyl] (4-methoxyphenyl)amino}naphthalen-2-yl)formamido]propanoate) 
in several solution conditions including its binding to human and bovine serum 
albumin proteins both in their native and denatured states. The fluorescence yield of 
the compound substantially increased inside hydrophobic protein surface and ~30 nm 
decrease in Stokes’ shift, compared to aqueous solution, was observed. Shift in fluores-
cence excitation peak position from the absorption peak of the molecule was ~8 nm 
in protein solution. This indicated possible alteration of excited state geometry of the 
compound by the globular fold of albumins. In addition, we measured the steady state 
fluorescence anisotropy of the molecule to evaluate several thermodynamic parameters 
and the results suggested the binding was energetically favorable. The measured ΔG° 
was ~−30 kJ mol−1 and the derived dissociation constant was ~10−6 M. The molecu-
lar docking analysis further highlighted the nonspecific association of the compound 
with the proteins and hydrophobic forces may have a significant role in the binding 
processes. Under the denatured condition of the protein, the compound lost its bind-
ing efficacy and reduction in fluorescence intensity was observed. Thus, the molecule 
appears as a new fluorescence probe to report the nature of its binding site in terms of 
increased fluorescence quantum yield and decreased Stokes’ shift. It can also report the 
changes in the binding site due to global change in protein structure such as unfolding/
misfolding often linked to several human disorder. Further it could be useful to detect 
and study the drug binding site of specific protein of interest.
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molecule in such microenvironment, in turn, carry information about the binding site, 
which is crucial for drug development (Royer 2006; Cohen et al. 2002; Abou-Zied and 
Al-Shini 2008; Er et al. 2013) and many other investigations. Our attention was focused 
on fluorescence emission and binding aspects of the fluorophore in the hydrophobic 
milieu inside a globular fold of a protein under physiological and denaturing conditions. 
We have synthesized a naphthalene based fluorophore, methyl 3-[(6-{[2-(tert-butoxy)-
2-oxoethyl](4-methoxyphenyl)amino}naphthalen-2-yl) formamido]propanoate (com-
pound 5) to study the immediate surroundings of the molecule inside the proteins.
Serum albumin was chosen as model protein with at least seven hydrophobic grooves 
on its surface. It provides a unique microenvironment and acts as a universal receptor 
for many drug molecules (Er et al. 2013; Reichenwallner and Hinderberger 2013; Simard 
et  al. 2006; Curry et  al. 1998). This protein increases the solubility of hydrophobic 
ligands in plasma and modulates their delivery to cells. The precise architecture of the 
binding pockets is known from several crystallographic and NMR spectroscopic studies 
(Reichenwallner and Hinderberger 2013; Simard et al. 2006; Curry et al. 1998). Thus, the 
interaction pattern and the spectroscopic signature of a small molecule housed in the 
well defined environment of serum albumin could provide significant insight into the 
interaction pattern and its binding efficacy (Yamasaki et al. 2013).
Intrinsic protein fluorescence originating from tryptophan and tyrosine residues or 
the fluorescence of the drug molecule itself provides ample information about the local 
environment, the changes in protein conformation and the interaction of a protein with 
a drug molecule (Royer 2006; Cohen et al. 2002; Abou-Zied and Al-Shini 2008). How-
ever, the current investigation explored both the quantitative and qualitative aspect of 
the interaction and incorporation of compound 5 into the binding pockets of serum 
albumin, at the molecular level using fluorescence methodologies. The thermodynamic 
parameters were obtained by measuring the effect of temperature on binding constant. 
In addition to access the interaction site and binding specificity of the drug molecule 
computational modeling analysis was carried out.
Methods
Chemicals
Bovine and human serum albumins were purchased from Sigma–Aldrich Corporation 
(St. Louis, MO, USA). Tris–HCl and Urea were also purchased from Sigma-Aldrich. All 
the samples were prepared in 20 mM Tris–HCl buffer of pH 7.0. Deionized and triple 
distilled water was used for preparing buffer solution that was passed through 0.22 µm 
pore size Millipore filters (Millipore India Pvt. Ltd., Bangalore, India).
All air and water sensitive reactions were carried out in oven dried glassware under 
nitrogen atmosphere using standard manifold techniques. All the chemicals were pur-
chased from Acros organics and Sigma-Aldrich, and used without further purification 
unless otherwise stated. Compounds that are not described in the experimental part 
were synthesized according to the literature procedures. Solvents were freshly distilled 
by standard procedures prior to use. Flash chromatography was performed on silica gel 
(Merck, 100–200 mesh) with the indicated elutant. All 1H and 13C-NMR spectra were 
recorded on a Bruker 600  MHz spectrometer. For 1H NMR, tetramethylsilane (TMS) 
served as internal standard (δ  =  0) and data are reported as follows: chemical shift, 
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integration, multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, m = multiplet) 
and coupling constant(s) in Hz. For 13C NMR, TMS (δ = 0) or CDCl3 (δ = 77.26) was 
used as internal standard and spectra were obtained with complete proton decoupling. 
Mass spectra were obtained on a Jeol MS station 700 and ESI-TOF mass spectrometer.
Procedure to synthesize compound 5
Synthesis was carried out following the Scheme 1. Detailed procedure and characteristic 
data are given in the Additional file 1.
Absorption spectroscopy
Ground-state absorption spectra were recorded with a Shimadzu UV-2401PC Spec-
trometer. 1 cm path-length quartz cuvette was used and 250–450 nm wavelength range 
was scanned. Compound 5 absorption spectra as a function of BSA and HSA concentra-
tion were recorded by titrating (Banerjee et al. 2012; Ray et al. 2012) compound 5 solu-
tion with concentrated protein solutions. Small dilution error in the titration experiment 
was ignored.
Fluorescence emission and excitation spectroscopy
The steady-state fluorescence emission and excitation spectra were recorded with a Cary 
Eclipse Fluorescence Spectrophotometer. The emission spectra of serum albumins and 
compound 5 were obtained by exciting the samples at the wavelengths 295 and 330 nm, 
respectively. The excitation spectra of compound 5 was obtained by recording the emis-
sion at wavelength 450  nm. In all the cases, the excitation and emission slit widths 
were kept at 5 nm each. Compound 5 fluorescence emission or excitation spectra as a 
Scheme 1 Reagent and conditions: a Conc. H2SO4, MeOH, 0 °C to r.t., 6 h. b Palladium (II) acetate (0.05 
equiv.), xantphos (0.1 equiv.) and cesium carbonate (3 equiv.), 80 °C, 4 h. c Potassium tert-butoxide (1.2 equiv.), 
DMF, 0 °C to r.t., 12 h. d Lithium hydroxide (3 equiv.), MeOH–water (5:1), r.t., 2 h. e EDC.HCl (3.0 equiv.), HOBT 
(2.5 equiv.), TEA (6 equiv.), 0 °C to r.t., 1.5 h
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function of protein concentration were recorded by simple titration method (Banerjee 
et al. 2012, 2013; Ray et al. 2012).
Fluorescence anisotropy
Fluorescence anisotropy experiments were performed in the Cary Eclipse Fluorescence 
Spectrophotometer and a manual polarizer accessory was used. The excitation and 
emission wavelengths were set to 330 and 450 nm, respectively, with slit widths of 5 nm 
for each monochromator. Anisotropy (r) was determined using the following equation 
(Banerjee et al. 2012):
where I is the fluorescence emission intensity when excitation and emission polarizes 
are aligned in a particular way denoted by the suffix. For example, VV indicates both the 
excitation and emission polarizers are vertically aligned whereas VH indicates excitation 
polarizer is vertical and the emission polarizer is horizontally aligned and so on. G is a 
correction factor.
The changes in compound 5 fluorescence anisotropy as a function of protein concen-
tration were recorded by simple titration method as mentioned earlier.
Determination of binding constants
Kd for compound 5 binding with BSA and HSA were determined from the compound 
5 fluorescence anisotropy perturbation with proteins. Compound 5 concentration was 
kept at 0.5 µM and the protein concentration was varied from 0 to 5.5 µM. Small dilu-
tion error due to the titration was ignored. Anisotropy values as a function of protein 
concentration were recorded. To derive the binding parameters, data were analyzed 
using the non-linear Langmuir isotherm (Banerji et al. 2013):
where Δr is the difference in fluorescence anisotropy in the absence and presence of the 
protein at concentration [P], Δrmax is the maximum possible change in the fluorescence 
anisotropy, Kd is the binding dissociation constant. The non-linear equation was fitted to 
the data using Wolfram Mathematica 10.
Stern–Volmer quenching constant or the binding affinity constant, Ka was determined 
as a reciprocal of Kd (Banerji et al. 2013).
Binding thermodynamics
Kd values were determined as a function of temperature and the thermodynamic param-
eters of binding was obtained by fitting van’t Hoff equation (Banerjee et  al. 2012; Ray 
et al. 2012) to the data:
where Keq is the equilibrium constant (here the Stern–Volmer quenching constant) of 
binding at corresponding temperature T, and R is the gas constant. The equation gives 
the standard enthalpy change (ΔH°) and standard entropy change (ΔS°) on binding. The 
(1)r = (IVV−G ∗ IVH)/(IVV + 2G ∗ IVH); G = IHV/IHH
(2)�r = �rmax ∗ [P]/(Kd + [P])
(3)ln Keq = −�H
◦/RT+�S◦/R
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free energy change (ΔG°) has been estimated from the following relationship (Banerjee 
et al. 2012; Ray et al. 2012):
Thermal and chemical denaturation
Thermal denaturation of protein was performed by increasing the temperature of the 
compound 5-protein solution from 10 to 80  °C in 8 steps (Banerjee et  al. 2012). The 
sample was kept under continuous stirring condition and the changes in compound 5 
fluorescence spectra were recorded. Chemical denaturation was achieved by increas-
ing the concentration of urea (Banerjee et  al. 2012) while recording the compound 5 
fluorescence.
Lipophilicity and solubility calculations
Lipophilicity in terms of calculated (clogP) and solubility in terms of calculated logS 
(clogS) were determined at Virtual Computational Chemistry Laboratory server (http://
www.vcclab.org/lab/alogps/) (Tetko et al. 2005). Polar surface area was calculated with a 
1.4 Å radius probe size.
Molecular docking
Molecular docking experiments were performed using AutoDock 4.2 (Morris et  al. 
2009) and AutoDock Vina (Trott and Olson 2010) of The Scripps Research Institute and 
the SwissDock server (http://www.swissdock.ch/). AutoDock 4.2, Vina and SwissDock 
uses different algorithm and scoring function for docking calculations. AutoDockTools 
(Morris et  al. 2009) was used for the preparation of ligands and proteins for docking. 
BSA (PDB: 3V03) (Majorek et al. 2012) and HSA (PDB: 1E78) (Bhattacharya et al. 2000) 
structural information were obtained from Protein Data Bank (Berman et al. 2000). The 
ligand structures were drawn in Avogadro (Hanwell et  al. 2012) and geometry opti-
mized in vaccuo using the steepest descent followed by conjugate gradient algorithms. 
Genetic algorithm was used in AutoDock 4.2 and it was run (ga_run) 100 times to gen-
erate a statistically significant number of docked poses (Alam et  al. 2012). AutoDock 
4.2 results were clustered using binding free energy and standard deviation cut offs of 
0.5 kcal mol−1 and 2Å, respectively.
Results and discussion
Absorbance and fluorescence of compound 5
In aqueous buffer at pH 7.4, Compound 5 shows a strong absorption band with a peak 
at 330 nm. Compound 5 is also fluorescence active and the fluorescence band appeared 
at ~450 nm (Fig. 1). Figure 1 also shows the excitation spectrum of compound 5, which 
largely overlapped with the absorption spectrum suggesting that excited state conforma-
tion of compound 5 in solution is homogeneous and close to ground state structure.
Fluorescence quantum yield of compound 5 in protein environment
Compound 5 absorbs UV–visible light strongly at the wavelengths where protein 
absorbs. It also has a strong absorption band in the fluorescence emission range of 
protein. Therefore, protein intrinsic fluorescence perturbation with compound 5 or 
(4)G◦ = H◦ − TS◦
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the energy transfer from protein to compound 5 is not an eminent choice to probe 
the binding interactions of compound 5 with proteins. However, the changes in com-
pound 5 fluorescence may be monitored as a parameter of binding. With the increasing 
concentration of serum albumins, we have found that the fluorescence intensity of the 
compound 5 increases (Fig. 2a, Additional file 1: Figure S1A). A blue shift in the emis-
sion maximum was also observed. It indicated compound 5 binding to the hydrophobic 
grooves of serum albumins. Such binding causes solvent exclusion of compound 5 and 
the energy that is otherwise spent in solvent relaxation, is gained by the emitting pho-
tons. Here, about 30 nm decrease in the Stokes’ shift in compound 5 fluorescence cor-
responds to ~0.2 eV energy gain by each emitted photon.
Interaction of compound 5 with serum albumins increases its fluorescence quantum 
yield and compound 5 gets a hydrophobic environments while bound to the serum albu-
mins. Thus, the changes in compound 5 fluorescence in the presence of proteins carry 
the information not only about the interaction but the microenvironment of the binding 
site on its target protein as well.



















Fig. 1 Absorption and fluorescence behavior of compound 5 in the UV–Visible range. Absorption spectrum 
of compound 5 in 20 mM Tris–HCl buffer of pH 7.4 is shown in blue. Fluorescence emission and excitation 
spectra of compound 5 are shown in green and yellow, respectively. Compound 5 fluorescence spectra were 
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Fig. 2 Fluorescence emission and anisotropy change of compound 5 in presence of serum albumin. 
Compound 5 concentration was kept constant at 0.5 μM and the protein concentration was varied from 
0 through 5.5 μM. a The changes in fluorescence emission spectrum of compound 5 as a function of BSA 
concentration. b The changes in compound 5 fluorescence anisotropy with increasing concentration of BSA 
and the fitted Langmuir isotherm
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Fluorescence anisotropy of compound 5 in presence of proteins
Small molecules tumble faster in less viscous solvents. But when it binds to a large mol-
ecule such as protein, its movement gets restricted. Fluorescence anisotropy is, there-
fore, widely used to measure the binding constants and kinetics of reactions that cause 
a change in the rotational time of the fluorescent molecules (Heyduk et al. 1996). Fluo-
rescence anisotropy measurements can also elucidate the microenvironment of a small 
molecule in terms of its rotational diffusion, interactions, and proximity to proteins. 
Compound 5 in buffer solution shows very low anisotropy. With the increasing con-
centration of serum albumins, fluorescence anisotropy of compound 5 increases and 
gradually reaches the saturation (Fig. 2b, Additional file 1: Figure S1B). Binding disso-
ciation constants for compound 5 binding with the two serum albumins were deter-
mined from this experiment and were found to be in the low micromolar concentration 
range (Table 1). The molecule showed increased quantum yield along with a blue shift 
in presence of protein. Anisotropy experiment confirmed that the molecule goes inside 
the binding cavity of the protein, thus, restricting its free rotation. Therefore, the anisot-
ropy suggests that the observed change in the fluorescence property of the molecule is a 
direct effect of the binding site environment.
Thermodynamics of compound 5 binding to serum albumins
Equilibrium constant of a reaction changes with the temperature (Fig. 3). Such a change 
can be explained by van’t Hoff’s equation, which in turn, gives the standard enthalpy 
and standard entropy changes for the reaction. The associations of the compound with 
serum albumins are thermodynamically favorable, which is evident from the decrease in 
Gibbs free energy (Table 2). Moreover, the binding with HSA is enthalpy driven (negative 
Table 1 The Kd and  Ka values for  the binding of  the compound 5 to  serum albumins 
as determined by the fluorescence and anisotropy perturbation experiments at room tem-
perature
Protein Kd (M) Ka (M
−1)
BSA 1.93 × 10−6 5.18 × 105
HSA 2.05 × 10−6 4.88 × 105
a




R 2 = 0.992
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Fig. 3 Determination of thermodynamic parameters of compound 5 binding from van’t Hoff’s plot. a 
Decrease in the binding equilibrium constant with the decreasing temperature for BSA-compound 5 interac-
tion and the fitted van’t Hoff equation. b Increase in the binding equilibrium constant with the decreasing 
temperature for HSA-compound 5 interaction and the fitted van’t Hoff equation
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ΔH°) whereas the binding with BSA is entropy driven (positive ΔS°). It suggests that, 
despite the structural similarity in the two proteins, the interactions with HSA are ther-
modynamically different from that of BSA.
Excited state geometry of compound 5 in protein environment
Fluorophore binding to a protein often results in an altered ground state electronic 
property, which can be visualized by a change in the absorption spectrum. However, the 
absorption spectrum of compound 5 does not change due to its binding with the serum 
albumins (Additional file  1: Figure S2). It indicates that the ground state geometry of 
compound 5 inside the hydrophobic groove of serum albumins remains the same as in 
the solution. Interestingly, when we recorded the excitation spectrum of compound 5 
in presence of serum albumins (Fig. 4, Additional file 1: Figure S3), we observed ~8 nm 
red shift in the wavelength of excitation maximum (330–338 nm). It indicates that the 
excited state geometry of compound 5 within the binding site of serum albumin gets 
altered with the possible formation of an exciplex.
Denaturation of proteins bound to compound 5
Serum albumin-compound 5 complexes were denatured chemically and thermally. 
When compound 5 is bound to the protein, fluorescence is blue shifted. With the grad-
ual increase in the temperature or the urea concentration, the fluorescence intensity of 
compound 5 gradually decreases and the Stokes’ shift increases until the fluorescence 
returns to its solution state nature (Fig. 5, Additional file 1: Figure S4). This experiment 
demonstrated that compound 5 binds to the structured protein and not to a denatured 
protein. In other words, it reports the progressive loss of binding sites on its receptor 
when the receptor is undergoing a massive structural change.
Table 2 Thermodynamics of compound 5 binding to serum albumins
Serum albumins ΔG° (kJ mol−1) at 25 °C ΔH° (kJ mol−1) ΔS° (J mol−1 K−1)
BSA −31.64 21.47 178.25
















































Fig. 4 Compound 5 binding is an excited state phenomenon. a The changes in compound 5 fluorescence 
excitation spectra upon addition of BSA. b Normalized absorption (blue) and fluorescence excitation (yellow) 
spectra of compound 5 overlapped with fluorescence excitation spectrum (green) in presence of BSA
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Drug like properties of compound 5
The molecular properties of the compound, such as clogP, clogS, polar surface area etc. 
(Bickerton et al. 2012) are listed in the Table 3. The clogP value of a compound is the 
logarithm of its partition coefficient between n-octanol and water. It is a well established 
measure of the compound’s lipophilicity, which influences its behaviour in a range of 
biological processes such as solubility, membrane permeability, lack of selectivity and 
non-specific toxicity (Alam et al. 2011). It has been shown for compounds to have a rea-
sonable probability of being well absorbed, their logP value must not be greater than 5.0 
(Lipinski et al. 1997). Besides, the aqueous solubility of a compound is also defined by 
logS, which significantly affects its absorption and distribution characteristics. Typically, 
a low solubility goes along with a bad absorption. Most of the drugs on the market have 
an estimated logS value of about −4. Table 3 lists the polar surface area of the compound 
as well, which should be less than 140 Å2 for a drug molecule (Lipinski et al. 1997). Apart 
from lipophilicity/solubility and the polar surface area, the molecular weight and the 
number of hydrogen bond acceptor/donor in compound 5 also follow the Lipinski’s rule 
of five (Lipinski et al. 1997) to be a candidate drug molecule.
Molecular modeling
In silico molecular docking calculation shows that the interactions of the compound 
with serum albumins are thermodynamically favorable (Table 4). The binding free ener-
gies computed by AutoDock Vina and SwissDock are very similar to that of the experi-
mentally obtained values (Table 2). Molecular docking also provides the insight into the 
most favorable binding site for these compounds on the serum albumins. The lowest 





















































Fig. 5 Compound 5 interaction with denaturing proteins. a The changes in fluorescence of BSA compound 
5 complex with the increasing temperature. b The changes in fluorescence of BSA compound 5 complex 
with the increasing concentration of Urea
Table 3 Molecular properties of compound 5
a The data represent mean ± SD
Molecular properties Values
logPa 4.56 ± 0.62
logS −5.97
Polar surface area 94.17 Å2
Lipinski’s rule of five Yes
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the binding sites for compound 5 lay in the groove between domain I and domain III 
of BSA, whereas it was within the domain I in case of HSA (Fig.  6, Additional file  1: 
Figure S5). This may, in part, explain the enthalpy driven nature of binding with HSA 
and the entropy driven binding with BSA (Table 2). Moreover, the non-specific nature 
of the binding is apparent from the lack of clustering in the AutoDock 4.2 results 
(Additional file 1: Figure S6). We have shown in earlier works that the low energy high 
frequency clusters in the AutoDock 4.2 output signifies specificity in the binding inter-
actions (Alam et al. 2012; Rudra et al. 2012; Bhowmik et al. 2013). Serum albumin with 
its many hydrophobic binding pockets acts like a universal receptor for almost all drug 
molecules. Binding to serum albumin is generally non-specific in nature and driven by 
mainly hydrophobic interactions, which is evident in the molecular docking results as 
well (Additional file 1: Figures S7, S8). 
Detailed interaction diagrams of the protein–ligand complexes showing the interact-
ing residues and the types of interactions obtained by three different docking programs 
(AutoDock 4.2, AutoDock Vina and SwissDock) are given in Additional file 1 (Figures 
S7, S8). The consensus of the interacting residues of BSA and HSA with compound 5 
are produced from those interacting diagrams depicted in Additional file 1: Figures S7, 
S8 and is shown in Fig. 7. We have found that Lys114 and His145 of BSA forms H-Bond 
Table 4 Theoretical binding free energies as obtained by molecular docking experiments 
using three different algorithms, AutoDock 4.2, AutoDock Vina and SwissDock
a The data represent mean ± SEM
Protein AutoDock 4.2 (kJ mol−1)a AutoDock Vina (kJ mol−1) SwissDock (kJ mol−1)
BSA −17.08 ± 0.35 −33.05 −36.15
HSA −20.78 ± 0.44 −35.56 −35.52
Fig. 6 Interaction of compound 5 with serum albumins as obtained from molecular docking experiments. a 
Best binding conformation of compound 5 with BSA and the close up view. b Best binding conformations of 
compound 5 with HSA; it is also shown in close up. AutoDock Vina generated complexes are depicted here. 
Proteins are shown in ribbon diagram and the ligands in stick model. The three domains of serum albumin are 
marked with I–III. Standard color representation is used to denote the elements, H, N and O in the ligand
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with compound 5, whereas, Arg458 forms pi-cation interaction. Other important inter-
acting residues of BSA are Arg144, Ser192, Pro110 and Leu189. In case of HSA, it is 
found that Arg117 and Tyr138 forms H-bond, whereas, Arg186 and Tyr161 forms pi-
stacking with compound 5. Other important interacting residues of HSA are Leu115, 
Phe157, Leu182, Leu185 and Gly189. 
a
b
Fig. 7 Detailed interaction diagram of compound 5 with serum albumins as obtained by molecular docking 
experiments. Only the residues common in all three lowest energy complexes generated by AutoDock 4.2, 
AutoDock Vina and SwissDock are shown. a Interacting residues of BSA and the types of interactions with 
compound 5. b Interacting residues of HSA and the types of interactions with compound 5
Page 12 of 13Pal et al. SpringerPlus  (2015) 4:548 
Conclusion
We have reported here, the spectroscopic behavior and binding parameters of a novel 
synthetic fluorophore in aqueous buffer and in the presence of albumin proteins. The 
compound showed drug like properties and bound to serum albumin with the binding 
constants in low micromolar concentration range. Moreover, the compound showed 
some interesting properties that could be used to probe the microenvironment, which 
reflect the immediate surroundings of the molecule inside the target proteins. The com-
pound binding to the hydrophobic sites of serum albumin significantly increased its 
fluorescence quantum yield, caused significant decrease in the Stokes’ shift indicating 
changes of excited state geometry of the molecule inside protein binding pocket. We 
observed an overall effect of the microenvironment of the binding site on the fluoro-
phore. Whether it was hydrophobicity alone or some other factor such as polarity or 
charge or a combination of all and how those environmental variables correlate with 
the fluorescence property of the molecule requires further elaborate experiment to 
understand. In the future experiment we plan to study the fluorescence properties of 
this molecule in different solution condition, micellar and liposomal or membranous 
environments.
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